SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Fairness Investigation Into Dun & Bradstreet Holdings, Inc. (NYSE: DNB) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) ('DNB') shareholders.
Click here for additional information: https://kaskelalaw.com/case/dun-bradstreet/.
On March 24, 2025, DNB announced that it had agreed to be acquired by private equity firm Clearlake Capital Group, L.P. at a price of $9.15 per share in cash. Following the closing of the proposed transaction, DNB's current stockholders will be cashed out of their investment position and the company's shares will no longer be publicly traded.
The investigation seeks to determine whether DNB shareholders are set to receive sufficient monetary consideration for their shares, and whether the company's officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to sell the company at $9.15 per share. Notably, shares of DNB's common stock traded above $12.00 per share as recently as February 2025, and at the time the proposed transaction was announced, several stock analysts were maintaining price targets for the company's shares above the proposed buyout price.
DNB shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options.
Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):
https://kaskelalaw.com/case/dun-bradstreet/
exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis, which means that the firm's clients never pay any out-of-pocket costs for legal representation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.
This notice may constitute attorney advertising in certain jurisdictions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Stablecoin Issuer Circle Surges 168% in NYSE Debut After IPO Tops Price Expectations
Shares of Circle Internet Group (NYSE:CRCL) jumped 168% on Thursday following its initial public offering, which raised nearly $1.1 billion for the stablecoin firm and its selling shareholders. The stock debuted at $69 on the New York Stock Exchange, well above its IPO price of $31, and at one point hit a high of $103.75. Circle Internet Group (NYSE:CRCL) set its IPO price late Wednesday, significantly above both the revised $27–$28 range earlier in the week and the initial $24–$26 estimate from last week, giving the company a valuation of around $6.8 billion before trading began. By the end of the day, trading volume hit approximately 46 million shares, well above the number of publicly available shares. CEO Jeremy Allaire made the following statement on CNBC's 'Money Movers' on Thursday: 'To realize our vision, we needed to forge relationships with governments, we needed to work with policymakers … because if you want this to work for mainstream, it's got to work in mainstream society and you need to have those rules of the road. We've been one of the most licensed, regulated, compliant, transparent companies in the entire history of this industry, and that's served us well.' Allaire co-founded Circle Internet Group (NYSE:CRCL) in 2013. Originally headquartered in Boston, the company began with a focus on consumer payment solutions, along with crypto wallet and exchange services. In 2015, it became the first company to secure the notoriously hard-to-get BitLicense from New York State. Earlier this year, Circle relocated its headquarters to New York. While we acknowledge the potential of CRCL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
UBS Upholds Buy Recommendation on Deckers Outdoor (DECK)
On June 5, UBS analysts maintained a Buy rating on Deckers Outdoor Corporation (NYSE:DECK) with a price target of $169. The analysts expect Decker's EPS to top market estimates over the coming year as sales projections increase for its Hoka brand. They also anticipate UGG to keep up its record as a major global casual footwear brand. A customer browsing a retail store, finding the perfect footwear for their casual outfits. The analysts were confident that Deckers Outdoor Corporation (NYSE:DECK) could deliver a low double-digit compound annual sales growth. They forecast that this growth could drive Deckers' forward PE ratio over 20x, compared to the present 16.7x. The $169 price target by UBS reflects a 60% upside for DECK. The stock has plummeted nearly 47% over the last six months, which signals a buying opportunity. After discussions with company management on June 4, the analysts were optimistic about Deckers Outdoor Corporation (NYSE:DECK)'s potential for growth. Despite the market showing caution with reference to the Hoka brand's capacity to sustain robust growth, UBS believes that DECK is perfectly tackling concerns about industry competition, evolving fashion trends, and dependence on Clifton and Bondi franchises. The analysts see double-digit revenue growth for Hoka in the next few years. Deckers Outdoor Corporation (NYSE:DECK) designs and markets premium footwear and apparel worldwide with brands like UGG and HOKA. The company was established in 1973 and is headquartered in Goleta, California. While we acknowledge the potential of DECK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio
